Skip to content

CareDx CDNA Incentive stock program, shares reserved for future grants (in shares)

Incentive stock program, shares reserved for future grants (in shares) at other companies

Guardant Health logo
Guardant HealthGH
Abbott logo
AbbottABT
Teladoc Health logo
Teladoc HealthTDOC

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's incentive stock program, shares reserved for future grants (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's incentive stock program, shares reserved for future grants (in shares)?
CareDx (CDNA) reported incentive stock program, shares reserved for future grants (in shares) of $1.86M in Q1 2026.
How has CareDx's incentive stock program, shares reserved for future grants (in shares) changed year-over-year?
CareDx's incentive stock program, shares reserved for future grants (in shares) increased by 10.2% year-over-year, from $1.68M to $1.86M.
What is the long-term trend for CareDx's incentive stock program, shares reserved for future grants (in shares)?
Over 4 years (2020 to 2024), CareDx's incentive stock program, shares reserved for future grants (in shares) has grown at a 61.3% compound annual growth rate (CAGR), from $672.97K to $4.56M.